Washington Institute for Coagulation (Part B/C) — Seattle, Washington

Washington Institute for Coagulation (Part B/C) is a clinical research site located in Seattle, Washington, United States 98101.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Washington Institute for Coagulation (Part B/C) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Glanzmann Thrombasthenia.

Sponsors: Hemab ApS.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington Institute for Coagulation (Part B/C)?

Washington Institute for Coagulation (Part B/C) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington Institute for Coagulation (Part B/C) conducted?

Washington Institute for Coagulation (Part B/C) has 1 clinical trials on record, with 1 currently active. Their work covers Glanzmann Thrombasthenia.

Is Washington Institute for Coagulation (Part B/C) accredited by Crixeo Health?

Washington Institute for Coagulation (Part B/C) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington Institute for Coagulation (Part B/C)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.